CoCensys Inc.: The Irvine developer of neuropharmaceutical...

CoCensys Inc.: The Irvine developer of neuropharmaceutical products reported a first-quarter loss of $4.6 million, or 50 cents a share, which included a onetime charge of $2 million advanced to an affiliate. That compared to a loss of $2.2 million, or 27 cents a share, for the first quarter of 1993. The company reported no revenue.